Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors show promise for treating hair loss in alopecia areata but need more clinical trials to confirm safety and effectiveness.

Oral cyclosporine is more effective and safer than betamethasone for treating alopecia areata.

Methylprednisolone infusions can help some people with severe alopecia regrow hair.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

Treating hair loss in both men and women is effective and improves quality of life.

A woman's hair loss from graft versus host disease helps understand similar hair loss conditions.

Alopecia areata in elderly people is usually mild and responds well to treatment.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Methotrexate alone is as effective and safe as combining it with prednisolone for treating Lichen planopilaris.

Baricitinib helped some patients with tough-to-treat hair loss regrow hair, but more research is needed on its safety.

PRP treatment may help with alopecia areata, especially in newer cases.

Patients with alopecia areata have higher oxidative stress and lower antioxidant levels.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Different causes of beard hair loss have various treatments, including medications, lifestyle changes, and procedures to stimulate hair growth.

Alopecia areata in children is usually mild and effectively treated with strong topical steroids.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Alopecia Areata affects people of all ages worldwide, is likely caused by genetic and environmental factors, and can lead to stress and depression, highlighting the need for treatments that address both physical and mental health.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Alopecia Areata is linked to a higher risk of several diseases, which vary with age and sex.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

The study concludes that Twenty-nail dystrophy is more common in boys among children and in women among adults, with varying response to treatment.

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.

Early diagnosis and treatment of nail lichen planus in children can prevent permanent nail damage.

Recognizing and managing skin-related psychiatric disorders in children is crucial for effective treatment.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Blood vessel patterns in skin diseases relate to certain blood markers in systemic sclerosis but not in psoriasis or psoriatic arthritis, and may indicate circulation issues in alopecia.